CANDACE HUNT: Open Payments
NPI 1710218748 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 27 payments from 12 companies in 2025. Trend: 2023 $904 · 2024 $649 · 2025 $685
Food & beverage: $651Education: $34
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 6 | $143 |
| CSL Behring | 3 | $78 |
| GENZYME CORPORATION | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $71 |
| Optinose US, Inc. | 3 | $69 |
| Genentech USA, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: NEFFY, DUPIXENT, TAKHZYRO, Xhance, Xolair, Andembry, PANZYGA, NUCALA.
Industry payments across TN — which companies pay providers there.
